Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session

Published 07/12/2022, 18:45
Updated 07/12/2022, 20:11
© Reuters.  Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session

© Reuters. Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session

Benzinga - Gainers

  • Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement.
  • BioVie Inc. (NASDAQ: BIVI) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107's potential in Parkinson's Disease (PD) and Alzheimer's Disease (AD).
  • Bit Brother Limited (NASDAQ: BTB) climbed 23.1% to $0.4680.
  • Vor Biopharma Inc. (NASDAQ: VOR) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.
  • FLJ Group Limited (NASDAQ: FLJ) gained 19.1% to $1.59.
  • MongoDB, Inc. (NASDAQ: MDB) climbed 18.6% to $171.54 after the company reported better-than-expected sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
  • Titan Medical Inc. (NASDAQ: TMDI) gained 17.8% to $0.7099. Titan Medical suspended special meeting of shareholders in conjunction with initiation of strategic review process.
  • Yield10 Bioscience, Inc. (NASDAQ: YTEN) climbed 15.6% to $2.0799. Yield10 Bioscience, last month, posted a Q3 loss of $0.71 per share.
  • Replimune Group, Inc. (NASDAQ: REPL) rose 15.5% to $21.82 after the company announced it entered into a collaboration angreement with Roche, and also announced initial data from the anti-PD1 failed melanoma cohort of the IGNYTE clinical trial and an RP2/3 program update.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) gained 14.2% to $0.4799. Hillstream BioPharma recently announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
  • NEXGEL, Inc. (NASDAQ: NXGL) gained 14.1% to $1.3690. NEXGEL reported share repurchase program of up to $500,000 of the company’s common stock.
  • Wearable Devices Ltd. (NASDAQ: WLDS) jumped 13.8% to $0.74.
  • Academy Sports and Outdoors, Inc. (NYSE: ASO) rose 13.1% to $55.75 after the company reported better-than-expected Q3 EPS results and raised its FY22 EPS guidance.
  • The Very Good Food Company Inc. (NASDAQ: VGFC) shares gained 12.4% to $0.0899 after dropping 17% on Tuesday. Very Good Food recently said it plans to launch its products at Albertsons Companies grocery stores across the U.S.
  • Qurate Retail, Inc. (NASDAQ: QRTEB) gained 10.7% to $7.50.
  • State Street Corporation (NYSE: NYSE:STT) climbed 10.4% to $82.11 after the company announced a $500 million increase to existing common share repurchases in Q4.
  • Alvotech (NASDAQ: ALVO) gained 9.6% to $7.54.
  • Meta Materials Inc. (NASDAQ: MMAT) rose 9.2% to $2.13 after climbing 14% on Tuesday.
  • China Eastern Airlines Corporation Limited (NYSE: CEA) jumped 7.7% to $20.56.
  • Selina Hospitality PLC (NASDAQ: SLNA) gained 7.5% to $3.0845.
Losers
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares dipped 52.2% to $1.0650 after the company announced pricing of a $4.1 million public offering.
  • iBio, Inc. (NYSE: IBIO) fell 50.9% to $0.7850 after the company reported pricing of $3.5 million underwritten public offering of 3,365,385 shares at $1.04 per share.
  • Versus Systems Inc. (NASDAQ: VS) fell 46.3% to $0.80 after the company announced pricing of a $2.1 million public offering.
  • Carvana Co. (NYSE: CVNA) dropped 44.2% to $3.7422 following a downgrade from Wedbush. Reports indicate that some of the company's largest creditors have signed a pact to prevent a potential creditor fight.
  • Daktronics, Inc. (NASDAQ: DAKT) fell 34.2% to $2.1850. Daktronics decided to delay earnings call 'in order to address the determination that there is substantial doubt about the Company's ability to continue as a going concern.'
  • Winc, Inc. (NYSE: WBEV) shares fell 31.9% to $0.2382 after dropping over 15% on Tuesday.
  • SCWorx Corp. (NASDAQ: WORX) dropped 30.1% to $0.5102.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) declined 27% to $0.1125.
  • Bruush Oral Care Inc. (NASDAQ: BRSH) declined 24% to $0.7218 after the company announced pricing of a $3 million private placement.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) dipped 22.2% to $0.2723.
  • Predictive Oncology Inc. (NASDAQ: POAI) fell 20% to $0.3949.
  • Mirati Therapeutics, Inc. (NASDAQ: MRTX) dropped 19.9% to $57.32. Mirati Therapeutics recently announced late-breaking results evaluating concurrent adagrasib and pembrolizumab in first-line advanced/metastatic non-small cell lung cancer.
  • Gossamer Bio, Inc. (NASDAQ: GOSS) declined 19.4% to $1.90 after multiple firms downgraded the stock.
  • Anghami Inc. (NASDAQ: ANGH) dropped 18.8% to $1.98.
  • Tempo Automation Holdings, Inc. (NASDAQ: TMPO) fell 18.5% to $2.72.
  • Castor Maritime Inc. (NASDAQ: CTRM) fell 16% to $1.3099.
  • Fangdd Network Group Ltd. (NASDAQ: DUO) fell 15.6% to $1.0633 after dropping more than 7% on Tuesday.
  • The Lovesac Company (NASDAQ: LOVE) dropped 15.3% to $19.05 after the company reported Q3 financial results.
  • Avid Bioservices, Inc. (NASDAQ: CDMO) declined 15.3% to $12.60 after the company posted a loss for the second quarter.
  • TROOPS, Inc. (NASDAQ: TROO) fell 15.1% to $1.80.
  • Smith & Wesson Brands, Inc. (NASDAQ: SWBI) dropped 15% to $10.03 after the company reported worse-than-expected Q2 EPS and sales results.
  • Cosmos Holdings Inc. (NASDAQ: COSM) shares fell 13.6% to $0.4064 after dipping 17% on Tuesday.
  • DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) dipped 12.8% to $9.25.
  • Uniti Group Inc. (NASDAQ: UNIT) declined 12.7% to $6.15.
  • Skillsoft Corp. (NYSE: SKIL) fell 12.3% to $1.6750 following weak quarterly sales.
  • INVO Bioscience, Inc. (NASDAQ: INVO) dropped 11.7% to $0.4149. The company, last month, posted downbeat quarterly results.
  • EZCORP, Inc. (NASDAQ: EZPW) declined 11.6% to $9.34 after the company announced a private offering of $175,000,000 of convertible senior notes due 2029.
  • Zuora, Inc. (NYSE: ZUO) fell 11.5% to $6.38 after the company issued weak revenue forecast.
  • Niu Technologies (NASDAQ: NIU) fell 11.5% to $4.46 after surging around 15% on Tuesday. Niu Technologies recently reported worse-than-expected Q3 EPS results.
  • United Natural Foods, Inc. (NYSE: UNFI) dropped 11.5% to $40.33 following downbeat quarterly earnings.
  • X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) shares fell 9.6% to $1.0850 after the company reported a proposed public offering.
  • Kingsoft Cloud Holdings Limited (NASDAQ: KC) fell 8.4% to $2.9850.
  • M&T Bank Corporation (NYSE: MTB) dropped 7.9% to $147.63 after Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform and lowered its price target from $215 to $180.
  • GDS Holdings Limited (NYSE: GDS) fell 7.6% to $16.83.
Also check this out Bitcoin Falls Below This Key Level; ImmutableX Among Top Losers.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.